ArticlePeerJ. Computer science2024
Hybrid transformer-CNN and LSTM model for lung disease segmentation and classification.
Article in PeerJ. Computer science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Interpretable hybrid ensemble with attention-based fusion and EAOO-GA optimization for lung cancer detection.Scientific reports · 2026Article
- Enhanced colorectal gland segmentation through multi-scale attention and contextual feature fusion.Scientific reports · 2026Article
- Clinically interpretable deep learning for breast cancer missense variant pathogenicity prediction.Frontiers in bioinformatics · 2026Article
- GlomNet: glomeruli segmentation network for WSI with diverse staining protocols for kidney disease diagnosis.Frontiers in medicine · 2026Article
- Nanomaterial-Based Molecular Imaging in Cancer: Advances in Simulation and AI Integration.Biomolecules · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
According to the World Health Organization (WHO) report, lung disorders are the third leading cause of mortality worldwide. Approximately three million individuals are affected with various types of lung disorders annually. This issue alarms us to take control measures related to early diagnostics, accurate treatment procedures,
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.